Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan

被引:28
|
作者
Alaaeldin, Rania [1 ]
Ali, Fares E. M. [2 ]
Bekhit, Amany Abdlrehim [3 ]
Zhao, Qing-Li [4 ]
Fathy, Moustafa [3 ,5 ]
机构
[1] Deraya Univ, Fac Pharm, Dept Biochem, Al Minya 61111, Egypt
[2] Al Azhar Univ, Fac Pharm, Dept Pharmacol & Toxicol, Assiut Branch, Assiut 71524, Egypt
[3] Minia Univ, Fac Pharm, Dept Biochem, Al Minya 61519, Egypt
[4] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Radiol, Toyama 9300194, Japan
[5] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Regenerat Med, Toyama 9300194, Japan
来源
MOLECULES | 2022年 / 27卷 / 22期
关键词
azilsartan; breast cancer; NF-kB; EMT; IL-6; JAK2; STAT3; SLUG; TWIST; SNAIL; NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; APOPTOSIS; RECEPTOR; EMT; COMBINATIONS; INFLAMMATION; MODULATION; MIGRATION; SLUG;
D O I
10.3390/molecules27227825
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metastatic breast cancer is an incurable form of breast cancer that exhibits high levels of epithelial-mesenchymal transition (EMT) markers. Angiotensin II has been linked to various signaling pathways involved in tumor cell growth and metastasis. The aim of this study is to investigate, for the first time, the anti-proliferative activity of azilsartan, an angiotensin II receptor blocker, against breast cancer cell lines MCF-7 and MDA-MB-231 at the molecular level. Cell viability, cell cycle, apoptosis, colony formation, and cell migration assays were performed. RT-PCR and western blotting analysis were used to explain the molecular mechanism. Azilsartan significantly decreased the cancer cells survival, induced apoptosis and cell cycle arrest, and inhibited colony formation and cell migration abilities. Furthermore, azilsartan reduced the mRNA levels of NF-kB, TWIST, SNAIL, SLUG and bcl2, and increased the mRNA level of bax. Additionally, azilsartan inhibited the expression of IL-6, JAK2, STAT3, MMP9 and bcl2 proteins, and increased the expression of bax, c-PARP and cleaved caspase 3 protein. Interestingly, it reduced the in vivo metastatic capacity of MDA-MBA-231 breast cancer cells. In conclusion, the present study revealed, for the first time, the anti-proliferative, apoptotic, anti-migration and EMT inhibition activities of azilsartan against breast cancer cells through modulating NF-kB/IL-6/JAK2/STAT3/MMP9, TWIST/SNAIL/SLUG and apoptosis signaling pathways.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment
    Manore, Sara G.
    Doheny, Daniel L.
    Wong, Grace L.
    Lo, Hui-Wen
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [42] Thidiazuron decreases epithelial-mesenchymal transition activity through the NF-kB and PI3K/AKT signalling pathways in breast cancer
    Rajendran, Peramaiyan
    Ben Ammar, Rebai
    Al-Saeedi, Fatma J.
    Mohamed, Maged Elsayed
    Islam, M. I. H.
    Al-Ramadan, Saeed Y.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (24) : 14525 - 14538
  • [43] IL-6 Promotes Head and Neck Tumor Metastasis by Inducing Epithelial-Mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway
    Yadav, Arti
    Kumar, Bhavna
    Datta, Jharna
    Teknos, Theodoros N.
    Kumar, Pawan
    MOLECULAR CANCER RESEARCH, 2011, 9 (12) : 1658 - 1667
  • [44] Protopanaxadiol inhibits epithelial-mesenchymal transition of hepatocellular carcinoma by targeting STAT3 pathway
    Yang, Lan
    Zhang, Xue-ying
    Li, Kun
    Li, An-ping
    Yang, Wen-dong
    Yang, Ru
    Wang, Peng
    Zhao, Zi-han
    Cui, Fang
    Qin, Yuan
    Yang, Jia-huan
    Tao, Hong-lian
    Sun, Tao
    Chen, Shuang
    Yu, Pei-hua
    Liu, Hui-juan
    Yang, Cheng
    CELL DEATH & DISEASE, 2019, 10 (9)
  • [45] Macrophage-secreted IL-8 induces-epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathway
    Fu, Xiu-Tao
    Dai, Zhi
    Song, Kang
    Zhang, Zhuo-Jun
    Zhou, Zheng-Jun
    Zhou, Shao-Lai
    Zhao, Yi-Ming
    Xiao, Yong-Sheng
    Sun, Qi-Man
    Ding, Zhen-Bin
    Fan, Jia
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (02) : 587 - 596
  • [46] BF211, a derivative of bufalin, enhances the cytocidal effects in multiple myeloma cells by inhibiting the IL-6/JAK2/STAT3 pathway
    Wu, Xiao-yu
    Tian, Fang
    Su, Min-hui
    Wu, Min
    Huang, Yue
    Hu, Li-hong
    Jin, Liang
    Zhu, Xue-jun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 64 : 24 - 32
  • [47] Glycochenodeoxycholate promotes the metastasis of gallbladder cancer cells by inducing epithelial to mesenchymal transition via activation of SOCS3/JAK2/STAT3 signaling pathway
    Wang, Hui
    Zhan, Ming
    Liu, Qiang
    Wang, Jian
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (02) : 1615 - 1623
  • [48] Inhibition of IL-6/STAT3 signaling in human cancer cells using Evista
    Shi, Wei
    Yan, Dan
    Zhao, Chongqiang
    Xiao, Miaomiao
    Wang, Yina
    Ma, Haiyan
    Liu, Tianshu
    Qin, Hua
    Zhang, Cuntai
    Li, Chenglong
    Lin, Jiayuh
    Li, Sheng
    Lv, Jiagao
    Lin, Li
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 491 (01) : 159 - 165
  • [49] STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells
    Zhang, Chuanhai
    Guo, Fenglin
    Xu, Geliang
    Ma, Jie
    Shao, Feng
    ONCOLOGY REPORTS, 2015, 33 (04) : 1872 - 1882
  • [50] Tumor-associated macrophages induce epithelial-mesenchymal transition and promote lung metastasis in breast cancer by activating the IL-6/STAT3/ TGM2 axis
    Qi, Yana
    Li, Ranran
    Han, Mingyong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143